CATALYST PHARMACEUTICALS, INC.·4

Dec 29, 4:45 PM ET

COELHO PHILIP H 4

4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 29, 2022

Insider Transaction Report

Form 4
Period: 2022-12-27
Transactions
  • Award

    Options to purchase common stock

    2022-12-27+15,000310,500 total
    Exercise: $18.59Exp: 2029-12-27Common Stock (15,000 underlying)
  • Award

    Restricted Stock Units

    2022-12-27+4,000314,500 total
    Common Stock (4,000 underlying)
Footnotes (3)
  • [F1]Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
  • [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 12-27-2022